Nasus Pharma Ltd Capital Units, Authorized
Nasus Pharma Ltd (NSRX) had Capital Units, Authorized of 22.80 million shares as of 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Notes
us-gaap:CapitalUnitsAuthorized · last filed 2026-03-25
- 2025-12-31: Capital Units, Authorized 22.80M shares.
- 2024-12-31: Capital Units, Authorized 13.27M shares.
| Period end | Capital Units, Authorized |
|---|---|
| 2025-12-31 | 22.80M shares 20-F · filed 2026-03-25 |
| 2024-12-31 | 13.27M shares 20-F · filed 2026-03-25 |